HUTCHMED (China) Limited
HCM · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2,633 | $2,632 | $3,436 | $4,656 |
| - Cash | $1,365 | $111 | $154 | $154 |
| + Debt | $93 | $101 | $90 | $90 |
| Enterprise Value | $1,362 | $2,622 | $3,371 | $4,592 |
| Revenue | $139 | $139 | $162 | $162 |
| % Growth | 0% | -14.4% | 0% | – |
| Gross Profit | $55 | $55 | -$28 | -$28 |
| % Margin | 39.7% | 39.7% | -17.4% | -17.4% |
| EBITDA | $1 | $1 | -$5 | -$5 |
| % Margin | 0.9% | 0.9% | -3.1% | -3.1% |
| Net Income | $227 | $227 | $6 | $6 |
| % Margin | 163.8% | 163.8% | 3.7% | 3.7% |
| EPS Diluted | 1.3 | 1.3 | 0.025 | 0.025 |
| % Growth | 0% | 5,100% | 0% | – |
| Operating Cash Flow | -$36 | -$36 | $20 | $20 |
| Capital Expenditures | -$5 | -$5 | -$4 | -$4 |
| Free Cash Flow | -$41 | -$41 | $16 | $16 |